US 9334522
Agents and methods to elicit anti-tumor immune response
granted A61KA61K2039/57A61K2239/38
Quick answer
US patent 9334522 (Agents and methods to elicit anti-tumor immune response) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon May 05 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue May 10 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 05 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K2039/57, A61K2239/38, A61K40/11, A61K40/42